Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Vortioxetine · Trintellix

Small molecule · Modulator of serotonin transporter (SLC6A4) · developed by Takeda Pharms Usa

Approved FDA, Sep 2013
TAK Developer
1 Registered trials

What is Vortioxetine?

Vortioxetine is an oral small molecule that inhibits serotonin reuptake and also acts as a 5-HT3 receptor antagonist and 5-HT1A receptor agonist in the central nervous system. It is used in the treatment of major depressive disorder.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Trintellix
Drug type
Small molecule
Targets
serotonin transporter (SLC6A4), 5-HT3 receptor (HTR3A) (secondary target), 5-HT1A receptor (HTR1A) (secondary target)
Mechanism
Modulator of serotonin transporter (SLC6A4)
Pathways
serotonergic neurotransmission
Therapy area
Psychiatry
Developer
Takeda Pharms Usa (TAK)
FDA status
Approved as Trintellix (September 30, 2013), NDA204447 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Apr 23, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07204314 Phase 3 Major Depressive Disorder Recruiting TAK

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Major Depressive Disorder

Other drugs acting on SLC6A4

More from Takeda Pharms Usa

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the TAK page.

Follow TAK, the company behind Vortioxetine

See TAK's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

TAK catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.